Last reviewed · How we verify
NCT07327099
Comparative Assessment of Arthrocentesis Methods in TMJ Disorders
NA trial testing Y-shaped cannula without a source in Temporomandibular Disorders (TMD) in 50 participants. Completed in 15 September 2025.
15 August 2025
Quick facts
| Lead sponsor | Helin Merve Özalp |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 August 2024 |
| Primary completion | 15 August 2025 |
| Estimated completion | 15 September 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Y-shaped cannula without a source
- Y-shaped cannula with a source
Conditions studied
- Temporomandibular Disorders (TMD) — all drugs for Temporomandibular Disorders (TMD) →
- Temporomandibular Joint Disc Displacement, With Reduction — all drugs for Temporomandibular Joint Disc Displacement, With Reduction →
Sponsor
Helin Merve Özalp
Who can join
Adults 17 to 75, any sex, with Temporomandibular Disorders (TMD) or Temporomandibular Joint Disc Displacement, With Reduction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Temporomandibular disorders (TMD) are common conditions in society, characterised by symptoms such as pain, limited movement and joint noises, which negatively affect an individual's quality of life. The primary goal of treatment is to restore the physiological functions of the joint by eliminating the aetiological factors. In cases where conservative methods prove ineffective, arthrocentesis, a minimally invasive approach, comes to the fore. Arthrocentesis aims to reduce pain by removing inflammatory mediators and to increase joint mobility. In this study, the intraoperative parameters and clinical outcomes of different arthrocentesis techniques were compared and evaluated in patients with Wilkes stage 2-3 TME disorders.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07327099
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Temporomandibular Disorders (TMD)
Currently open trials in the same condition.
- NCT07474662 — Comparing the Effectiveness of Online vs. Face-to-face Physiotherapy for Treating Temporomandibular Disorders · NA · recruiting
- NCT07445516 — Occlusal Equilibration vs. Sham Therapies for TMDs: Post-Trial Follow-up (OEST) · recruiting
- NCT07373184 — Virtual Planning of Total Temporomandibular Joint Replacement · recruiting
- NCT06932406 — Orofacial Pain Self-management: Personality Moderation Effect · NA · recruiting
- NCT07075276 — Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07327099 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Helin Merve Özalp
- Last refreshed: 9 April 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07327099.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing